Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here is one profitable company that leverages its financial strength to beat the competition and two that may face some trouble.
Two Stocks to Sell:
Zimmer Biomet (ZBH)
Trailing 12-Month GAAP Operating Margin: 14.2%
With a history dating back to 1927 and a presence in over 100 countries worldwide, Zimmer Biomet (NYSE:ZBH) designs and manufactures orthopedic products including knee and hip replacements, surgical tools, and robotic technologies for joint reconstruction and spine surgeries.
Why Are We Hesitant About ZBH?
- Annual revenue growth of 4.4% over the last five years was below our standards for the healthcare sector
- Incremental sales over the last five years were less profitable as its 2.4% annual earnings per share growth lagged its revenue gains
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
Zimmer Biomet is trading at $100.27 per share, or 11.3x forward P/E. Dive into our free research report to see why there are better opportunities than ZBH.
Perella Weinberg (PWP)
Trailing 12-Month GAAP Operating Margin: 2.8%
Founded in 2006 by veteran investment bankers Joseph Perella and Peter Weinberg during a wave of boutique advisory firm launches, Perella Weinberg Partners (NASDAQ:PWP) is a global independent advisory firm that provides strategic and financial advice to corporations, financial sponsors, and government institutions.
Why Should You Sell PWP?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 1.3% annually over the last five years
- Earnings per share have dipped by 13.9% annually over the past four years, which is concerning because stock prices follow EPS over the long term
At $16.68 per share, Perella Weinberg trades at 12.6x forward P/E. If you’re considering PWP for your portfolio, see our FREE research report to learn more.
One Stock to Watch:
Korn Ferry (KFY)
Trailing 12-Month GAAP Operating Margin: 12.8%
With clients including 97% of the S&P 100 and operations in 103 offices across 51 countries, Korn Ferry (NYSE:KFY) is a global consulting firm that helps organizations design optimal structures, recruit talent, develop leaders, and create effective compensation strategies.
Why Do We Like KFY?
- Annual revenue growth of 10.1% over the past five years was outstanding, reflecting market share gains this cycle
- Earnings per share have massively outperformed its peers over the last two years, increasing by 26.9% annually
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures
Korn Ferry’s stock price of $83.59 implies a valuation ratio of 14.6x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.